Affivant is a company dedicated to developing novel immune-oncology approaches to activate and enable the innate immune system to fight cancer. Their innovative bi-specific innate cell engagers are designed to target specific patient populations as powerful monotherapies and combination treatments.
Location: Switzerland, Basel-City, Basel
Employees: 11-50
Investors 2
| Date | Name | Website |
| 25.03.2024 | VentureLab | venturelab... |
| - | Roivant | roivant.co... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 19.04.2023 | Ten biotech startups head to Boston | startuptic... |